Empagliflozin improves left ventricular ejection fraction and end systolic volume in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD trial
{"title":"Empagliflozin improves left ventricular ejection fraction and end systolic volume in patients with type 2 diabetes mellitus and coronary artery disease: a post-hoc analysis of EMPA-CARD trial","authors":"Samin Ghanbari, Sepehr Gohari, Tara Reshadmanesh, Mahsa Mahjani, Shahram Arsang-Jang, Faramarz Ismail-Beigi, Mohsen Dadashi, Hossein Chiti, Atieh Asgari, Homa Taheri, Ozra Zolfkhani, H. Ahangar","doi":"10.1007/s40200-024-01393-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":313858,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"41 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes & Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-024-01393-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
